Btr Raises $15 Million In Series A Round To Transform The Validation Process For Life Sciences Companies
Btr Raises $15 Million In Series A Round To Transform The Validation Process For Life Sciences Companies
02/09/22, 12:05 PM
Location
bostonMoney raised
$15 million
Round Type
series a
BTR (Boston Technology Research), a regulatory technology company serving healthcare, life sciences and SaMD, today announced that is has raised $15 million in a Series A round led by New York-based global venture capital and private equity firm Insight Partners, with participation from LRV Health, NewStack Ventures and other investors. The new funding will be used to ensure that customers are prepared for the FDA’s anticipated guidance that will incentivize a move from traditional methods to new technologies.
Company Info
Location
boston, massachusetts, united states
Additional Info
BTR is a regulatory technology company serving healthcare, life sciences and SaMD. It has been the compliance engine behind leading software vendors such as Veeva, Nuvolo and Benchling, and has helped more than 275 healthcare and life sciences companies transition to the regulated cloud. BTR’s enterprise-wide compliance platform is used across leading software vendors and sponsors alike, including customers, like Glaukos, Dermavant, Lexicon and Atsena. BTR is headquartered in Chelsea, MA, with a global workforce located throughout North America, Europe and Asia.
To learn more about the company’s seamless validation solutions including a demo, please visit BostonTR.com, email the team at info@bostontr.com or follow us on LinkedIn.